---
pmid: '31242413'
title: HSF2BP Interacts with a Conserved Domain of BRCA2 and Is Required for Mouse
  Spermatogenesis.
authors:
- Brandsma I
- Sato K
- van Rossum-Fikkert SE
- van Vliet N
- Sleddens E
- Reuter M
- Odijk H
- van den Tempel N
- Dekkers DHW
- Bezstarosti K
- Demmers JAA
- Maas A
- Lebbink J
- Wyman C
- Essers J
- van Gent DC
- Baarends WM
- Knipscheer P
- Kanaar R
- Zelensky AN
journal: Cell Rep
year: '2019'
full_text_available: false
doi: 10.1016/j.celrep.2019.05.096
---

# HSF2BP Interacts with a Conserved Domain of BRCA2 and Is Required for Mouse Spermatogenesis.
**Authors:** Brandsma I, Sato K, van Rossum-Fikkert SE, van Vliet N, Sleddens E, Reuter M, Odijk H, van den Tempel N, Dekkers DHW, Bezstarosti K, Demmers JAA, Maas A, Lebbink J, Wyman C, Essers J, van Gent DC, Baarends WM, Knipscheer P, Kanaar R, Zelensky AN
**Journal:** Cell Rep (2019)
**DOI:** [10.1016/j.celrep.2019.05.096](https://doi.org/10.1016/j.celrep.2019.05.096)

## Abstract

1. Cell Rep. 2019 Jun 25;27(13):3790-3798.e7. doi: 10.1016/j.celrep.2019.05.096.

HSF2BP Interacts with a Conserved Domain of BRCA2 and Is Required for Mouse 
Spermatogenesis.

Brandsma I(1), Sato K(2), van Rossum-Fikkert SE(3), van Vliet N(1), Sleddens 
E(4), Reuter M(1), Odijk H(1), van den Tempel N(1), Dekkers DHW(5), Bezstarosti 
K(5), Demmers JAA(5), Maas A(6), Lebbink J(3), Wyman C(3), Essers J(7), van Gent 
DC(1), Baarends WM(4), Knipscheer P(8), Kanaar R(9), Zelensky AN(10).

Author information:
(1)Department of Molecular Genetics, Oncode Institute, Erasmus University 
Medical Center, 3000 CA Rotterdam, the Netherlands.
(2)Oncode Institute, Hubrecht Institute-KNAW and University Medical Center 
Utrecht, 3584 CT Utrecht, the Netherlands.
(3)Department of Molecular Genetics, Oncode Institute, Erasmus University 
Medical Center, 3000 CA Rotterdam, the Netherlands; Department of Radiation 
Oncology, Erasmus University Medical Center, 3000 CA Rotterdam, the Netherlands.
(4)Department of Developmental Biology, Erasmus University Medical Center, 3000 
CA Rotterdam, the Netherlands.
(5)Proteomics Center, Erasmus University Medical Center, 3000 CA Rotterdam, the 
Netherlands.
(6)Department of Cell Biology, Erasmus University Medical Center, 3000 CA 
Rotterdam, the Netherlands.
(7)Department of Molecular Genetics, Oncode Institute, Erasmus University 
Medical Center, 3000 CA Rotterdam, the Netherlands; Department of Radiation 
Oncology, Erasmus University Medical Center, 3000 CA Rotterdam, the Netherlands; 
Department of Vascular Surgery, Erasmus University Medical Center, 3000 CA 
Rotterdam, the Netherlands.
(8)Oncode Institute, Hubrecht Institute-KNAW and University Medical Center 
Utrecht, 3584 CT Utrecht, the Netherlands. Electronic address: 
p.knipscheer@hubrecht.eu.
(9)Department of Molecular Genetics, Oncode Institute, Erasmus University 
Medical Center, 3000 CA Rotterdam, the Netherlands. Electronic address: 
r.kanaar@erasmusmc.nl.
(10)Department of Molecular Genetics, Oncode Institute, Erasmus University 
Medical Center, 3000 CA Rotterdam, the Netherlands. Electronic address: 
a.zelensky@erasmusmc.nl.

The tumor suppressor BRCA2 is essential for homologous recombination (HR), 
replication fork stability, and DNA interstrand crosslink repair in vertebrates. 
We identify HSF2BP, a protein previously described as testis specific and not 
characterized functionally, as an interactor of BRCA2 in mouse embryonic stem 
cells, where the 2 proteins form a constitutive complex. HSF2BP is transcribed 
in all cultured human cancer cell lines tested and elevated in some tumor 
samples. Inactivation of the mouse Hsf2bp gene results in male infertility due 
to a severe HR defect during spermatogenesis. The BRCA2-HSF2BP interaction is 
highly evolutionarily conserved and maps to armadillo repeats in HSF2BP and a 
68-amino acid region between the BRC repeats and the DNA binding domain of human 
BRCA2 (Gly2270-Thr2337) encoded by exons 12 and 13. This region of BRCA2 does 
not harbor known cancer-associated missense mutations and may be involved in the 
reproductive rather than the tumor-suppressing function of BRCA2.

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

DOI: 10.1016/j.celrep.2019.05.096
PMID: 31242413 [Indexed for MEDLINE]
